Study on ocular safety and procedure optimization of UV - riboflavin scleral collagen cross-linking in single blind eyes

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042422

Enrollment

Unknown

Registered

2021-01-21

Start date

2021-01-22

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pathologic myopia

Interventions

experimental group:CXL

control group:PSR

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Blindness due to pathological changes in high myopia.

Exclusion criteria

Exclusion criteria: Acute inflammation of the anterior segment, dacryocystitis, corneal pannus, cataract, staphylostoma sclera, scleritis, uveitis, ocular trauma, retinal detachment, proliferative vitreoretinopathy.

Design outcomes

Primary

Measure	Time frame
Corneal endothelium number;ERG;blood flow ultrasound;local response;	—

Secondary

Measure	Time frame
AL;refractive diopter;Choroidal thickness;	—

Countries

China

Contacts

Public ContactZhang Fengju

Beijing Tongren Hospital, Capital Medical University

zhangfj126@126.com+86 18601287753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026